Chardan Capital Maintains Buy on EyePoint, Raises Price Target to $65
Chardan Capital analyst Andreas Argyrides maintains EyePoint (NASDAQ: EYPT ) with a Buy and raises the price target from $29 to $65.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.